← Back to headlines
Evolus outlines 2026 revenue guidance of $327M–$337M while expanding international presence and product portfolio
Evolus, a medical aesthetics company, has outlined its revenue guidance for 2026, projecting $327M–$337M, alongside plans for expanding its international presence and product portfolio.
4 Mar, 07:42 — 4 Mar, 07:42
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Nigerian Government Partners with GIZ to Enforce Solar Mini-Grid Standards
just now
Trade minister demands measurable outcomes for AfCFTA gains, WTO leverage
just now
Cyprus Electricity Authority Faces Challenges from Aging Plants and Competition
4m ago
Putyin: Miért ne állíthatnánk le már most a gázszállítást Európába?
5m ago